When it comes to streamlining trials, this technology allows laboratories to create patient models prior to the trial taking place – enabling researchers to better assess the potential effects of drug candidates on various patient types in the experimental arm and reduce their dependence on control groups. By utilising virtual twin technology, researchers can identify the risks and predict the results of a drug candidate using models of real patients rather than isolated tissues or animal models. The use of this technology within clinical trials has three main objectives:
Comments